Tuesday, May 15, 2012 7:28:30 PM
Second, the sales will increase the value of ARNA. This is enticing to other companies for any possible buy out, or if the drug is not approved for whatever reason the company will not tank because of it. ARNA could basically settle any debts, and look very favorable to a suitor.
If you check out http://www.eisai.com/news/news201224.html EISAI is also doing something interesting not sure what......
Either way, when you bought into this company, you invested your DD and time and money, for a return. I still believe that ARNA will be successful on 6-27. We may only see 18-20 dollars instead of 22-25 dollars, who knows. I personally will be taking advantage of these cheap shares.....glty
FEATURED CBD Life Sciences, Inc. (CBDL) Reaches Unprecedented Heights With Explosive Growth and Strategic Expansion in 2024 • Oct 8, 2024 8:00 AM
BNCM COMPLETES MERGER WITH DELEX HEALTHCARE • BNCM • Oct 8, 2024 9:54 AM
Unitronix Corp. to Invest $3 Million in USA Unity Coin Project • UTRX • Oct 7, 2024 7:08 AM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM